| Counseling Center For Growth And Recovery, Llc | |
|
100 E Linton Blvd Suite 155a Delray Beach FL 33483-3327 | |
| (561) 404-1482 | |
| (561) 819-9822 |
| Full Name | Counseling Center For Growth And Recovery, Llc |
|---|---|
| Speciality | Social Worker |
| Location | 100 E Linton Blvd, Delray Beach, Florida |
| Authorized Official Name and Position | Irving Schattner (DIRECTOR) |
| Authorized Official Contact | 5613020701 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Counseling Center For Growth And Recovery, Llc 603 Andrews Ave Delray Beach FL 33483-7207 Ph: (561) 302-0701 | Counseling Center For Growth And Recovery, Llc 100 E Linton Blvd Suite 155a Delray Beach FL 33483-3327 Ph: (561) 404-1482 |
| NPI Number | 1639574171 |
|---|---|
| Provider Enumeration Date | 10/27/2014 |
| Last Update Date | 07/27/2015 |
| Medicare PECOS PAC ID | 7719202589 |
|---|---|
| Medicare Enrollment ID | O20150219001294 |
News Archive
Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
"Would legal regulation and control of drugs better protect children?" is a question posed by former President of Brazil, Fernando Henrique Cardoso in an editorial to be published in the January issue of Elsevier's International Journal of Drug Policy (IJDP).
An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639574171 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW11390 (Florida) | Primary |
| Provider Name | Irving Schattner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1346674827 PECOS PAC ID: 5294053419 Enrollment ID: I20150417001268 |
News Archive
Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
"Would legal regulation and control of drugs better protect children?" is a question posed by former President of Brazil, Fernando Henrique Cardoso in an editorial to be published in the January issue of Elsevier's International Journal of Drug Policy (IJDP).
An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
News Archive
Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
"Would legal regulation and control of drugs better protect children?" is a question posed by former President of Brazil, Fernando Henrique Cardoso in an editorial to be published in the January issue of Elsevier's International Journal of Drug Policy (IJDP).
An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
Intervention Strategies, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 297 Ne 6th Ave, Delray Beach, FL 33483 Phone: 561-243-0407 Fax: 561-243-0030 | |
Jacqueline B Pevny Md Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2040 Alta Meadows Ln, Suite 1601, Delray Beach, FL 33444 Phone: 561-272-4888 | |
Carl A Salvati M D P A Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13455 Military Trl, Suite A, Delray Beach, FL 33484 Phone: 561-495-4644 Fax: 561-495-5191 | |
U Turn Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 206 Sw 13th Ave, Delray Beach, FL 33444 Phone: 954-746-8232 Fax: 954-746-8981 | |
Holistic Home & Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15200 Jog Rd, 303, Delray Beach, FL 33446 Phone: 828-237-1238 | |
Boca Palms Medical Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Congress Park Dr, Suite 100, Delray Beach, FL 33445 Phone: 561-361-6608 Fax: 561-361-9857 | |
Brian Gong Psychotherapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Linton Blvd, Suite 200-a, Delray Beach, FL 33444 Phone: 561-501-1008 Fax: 561-431-2608 |